Effects of conventional and sugar-free energy drinks intake in runners: a double-blind, randomized, placebo-controlled crossover clinical trial

被引:0
|
作者
Reis, Hamilton H. [1 ]
Lima, Luciana M. [2 ]
Reis, Victoria E. [3 ]
Mota-Junior, Romulo J. [1 ]
Soares-Junior, Duilio T. [1 ]
Sillero-Quintana, Manuel [4 ]
Rasmussen, Heather E. [3 ]
Carneiro-Junior, Miguel A. [1 ]
Marins, Joao B. [1 ]
机构
[1] Univ Fed Vicosa, Dept Phys Educ, Vicosa, MG, Brazil
[2] Univ Fed Vicosa, Dept Med & Nursing, Vicosa, MG, Brazil
[3] Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE USA
[4] Tech Univ Madrid, Fac Phys Act & Sports Sci, Sports Dept, Madrid, Spain
来源
关键词
Caffeine; Taurine; Sports Nutritional Physiological Phenomena; Athletic performance; Nutritive value; RED-BULL; PERFORMANCE; CAFFEINE; INGESTION; EXERCISE; OUTCOMES; ADULTS;
D O I
10.23736/S0022-4707.20.11601
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
BACKGROUND: This study evaluated the effects of two types of energy drinks (ED) intake in trained runners. METHODS: A double-blind randomized placebo-controlled clinical trial was conducted over 6 weeks. Participants and beverages were allocated by randomization. Twelve men 23 +/- 2.6 years, 177 +/- 3.4 cm, 74.4 +/- 5.5 kg, VO2max=59.8 +/- 5.5 mL.(kg.min)(-1)] ingested either a conventional energy drink containing carbohydrates and 3 mg.kg(-1) of caffeine, (ED1), a sugar-free energy drink 3 mg.kg(-1) of caffeine (ED2), or a carbohydrate-containing, decaffeinated placebo (PL) 40-minutes before an exercise protocol. Sprint time, rate of perceived exertion (RPE), respiratory exchange ratio (RER), blood pressure (BP), heart rate and plasmatic glucose were evaluated during the experimental protocol. RESULTS: Performance improved after consuming both ED (P<0.004 ED1 and P=0.001 ED2) with lower RPE (P<0.05 for ED1 and P<0.05 for ED2) compared to PL. Consumption of ED2 decreased RER values at 0-5 minutes and 40-45 minutes (P<0.001), and ED1 increased systolic BP (P<0.05) during exercise compared to PL. There were no differences in the evaluated parameters between EDs (P>0.05). CONCLUSIONS: Consumption of conventional or sugar free ED represents a valid ergogenic strategy to improve acute performance with reduction of RPE. However, intake of a conventional ED warrants caution, mainly because the effects on systolic BP.
引用
收藏
页码:928 / 934
页数:7
相关论文
共 50 条
  • [1] Metabolic and hormonal effects of caffeine: randomized, double-blind, placebo-controlled crossover trial
    MacKenzie, Todd
    Comi, Richard
    Sluss, Patrick
    Keisari, Ronit
    Manwar, Simone
    Kim, Janice
    Larson, Robin
    Baron, John A.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (12): : 1694 - 1698
  • [2] Immunomodulatory Effects of Saffron: A Randomized Double-Blind Placebo-Controlled Clinical Trial
    Kianbakht, S.
    Ghazavi, A.
    [J]. PHYTOTHERAPY RESEARCH, 2011, 25 (12) : 1801 - 1805
  • [3] Tetracycline and epidermolysis bullosa simplex: a double-blind, placebo-controlled, crossover randomized clinical trial
    Weiner, M
    Stein, A
    Cash, S
    de Leoz, J
    Fine, JD
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (03) : 613 - 614
  • [4] Suppression of tics with baclofen: Double-blind, placebo-controlled, crossover clinical trial
    Singer, HS
    Krieger, M
    Wendlandt, JT
    Guiliano, J
    [J]. ANNALS OF NEUROLOGY, 2000, 48 (03) : 544 - 545
  • [5] Gabapentin for Parkinsonism: A double-blind, placebo-controlled, crossover trial
    Olson, WL
    Gruenthal, M
    Mueller, ME
    Olson, WH
    [J]. AMERICAN JOURNAL OF MEDICINE, 1997, 102 (01): : 60 - 66
  • [6] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    [J]. OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
  • [7] Treatment of chronic constipation with colchicine: Randomized, double-blind, placebo-controlled, crossover trial
    Verne, GN
    Davis, RH
    Robinson, ME
    Gordon, JM
    Eaker, EY
    Sninksy, CA
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (05): : 1112 - 1116
  • [8] Randomized, double-blind, placebo-controlled crossover trial of Famotidine in patients with functional dyspepsia
    Kato, Mototsugu
    Yoshida, Takeshi
    Hata, Tamotsu
    Ono, Yuji
    Ono, Shouko
    Nakagawa, Manabu
    Nakagawa, Souichi
    Shimizu, Yuichi
    Asaka, Masahiro
    [J]. GASTROENTEROLOGY, 2006, 130 (04) : A158 - A158
  • [9] Improvement of erectile function with Prelox: a randomized, double-blind, placebo-controlled, crossover trial
    R Stanislavov
    V Nikolova
    P Rohdewald
    [J]. International Journal of Impotence Research, 2008, 20 : 173 - 180
  • [10] Tolcapone in Obsessive Compulsive Disorder: A Randomized Double-Blind Placebo-Controlled Crossover Trial
    Grant, Jon
    Chamberlain, Samuel
    [J]. NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 312 - 313